# Monteris Medical US

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/monteris-medical-us

- Industry: Medical Devices & Equipment
- Headquarters: Minnetonka, US
- Website: www.monteris.com
- Total disclosed funding: $98M
- Latest round: Series E (Mar 12, 2026)
- Investors on record: 10

## About

Monteris Medical US, Inc., based in the US, specializes in minimally invasive brain surgery, providing advanced solutions for neurosurgical applications aimed at enhancing patient outcomes through innovative technology.Founded in 1999 and headquartered in Minnetonka, US, Monteris Medical US, Inc. focuses on developing advanced neurosurgical solutions. The company has pivoted towards utilizing robotic MR-guided laser ablation technology through its flagship NeuroBlate® System. In its funding history, Monteris has raised USD 13.70 mn, including a recent USD 28 mn VENTURE DEBT round in October 2022 from Madryn Asset Management, Lp, to support its growth initiatives.Monteris specializes in advancing minimally invasive brain surgery through its flagship product, the NeuroBlate® System, which employs robotic MR-guided laser ablation technology specifically designed for neurosurgical applications. The NeuroBlate® System utilizes a cooled laser probe with the smallest diameter available, enabling precise ablation of various lesion sizes in the brain, including tumors, radiation necrosis, and conditions associated with drug-resistant epilepsy. This innovative technology caters to healthcare professionals and institutions, including hospitals and specialized clinics, providing them with the tools necessary to enhance patient outcomes in complex neurological cases. Monteris’s offerings are tailored for deployment in various geographical markets, including the United States and Canada, where there is a pressing need for advanced surgical techniques in the treatment of brain-related ailments.Monteris generates revenue primarily through the sale of its NeuroBlate® System and associated disposables, which are essential for conducting procedures. The business model entails direct transactions with healthcare providers and institutions, whereby these clients purchase the NeuroBlate® System and necessary consumables to facilitate laser ablation procedures. Revenue is structured through device sales and recurring sales of disposables required for ongoing procedures, ensuring a continuous revenue stream from existing clients. The NeuroBlate® System is a critical asset in neurosurgical practices, underscoring Monteris's commitment to clinical excellence and innovation in neurological healthcare.In October 2022, Monteris Medical US, Inc. raised USD 28 mn in VENTURE DEBT funding, including an additional USD 10 mn contingent on achieving certain milestones. The company aims to leverage this funding for increasing market adoption, advancing clinical research, and enhancing its technology programs while refinancing existing obligations. Monteris plans to expand its geographic footprint, targeting new markets and regions to widen the impact of its NeuroBlate® System and improve the treatment of neurological conditions.

## Funding rounds

- Series E, Mar 12, 2026, $28M — Birchview Capital, OSF HealthCare, OSF Ventures, Madryn Asset Management, InnovaHealth Partners, Colorado University Healthcare Innovation Fund
- Series D, Sep 2, 2022, $14M — Birchview Capital, InnovaHealth Partners
- Series C, May 17, 2017, $27M — Versant Ventures, BDC Capital, SightLine Partners, Birchview Capital
- Series B, Nov 12, 2014, $30M — BDC Capital, Vertical Group, Birchview Capital

## Investors

- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Series B, Series C
- Vertical Group (https://capitalatlas.ai/funds/vertical-group) — Series B
- Birchview Capital (https://capitalatlas.ai/funds/birchview-capital) — Series B, Series C, Series D, Series E
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series C
- SightLine Partners — Series C
- InnovaHealth Partners (https://capitalatlas.ai/funds/innovahealth-partners) — Series D, Series E
- OSF HealthCare — Series E
- OSF Ventures (https://capitalatlas.ai/funds/osf-ventures) — Series E
- Madryn Asset Management (https://capitalatlas.ai/funds/madryn-asset-management) — Series E
- Colorado University Healthcare Innovation Fund — Series E